Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2107-0180
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling ; volume:47 ; number:6 ; day:30 ; month:9 ; year:2022 ; pages:855-868 ; date:11.2022
European journal of drug metabolism and pharmacokinetics ; 47, Heft 6 (30.9.2022), 855-868, 11.2022
- Urheber
-
Kinvig, Hannah
Cottura, Nicolas
Lloyd, Andrew
Frivold, Collrane
Mistilis, Jessica
Jarrahian, Courtney
Siccardi, Marco
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13318-022-00793-6
- URN
-
urn:nbn:de:101:1-2023022321083363662709
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kinvig, Hannah
- Cottura, Nicolas
- Lloyd, Andrew
- Frivold, Collrane
- Mistilis, Jessica
- Jarrahian, Courtney
- Siccardi, Marco
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis
Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Microneedle‐Mediated Cell Therapy
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis
Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Microneedle‐Mediated Cell Therapy
Correction to: Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling
Drug resistance emergence in macaques administered cabotegravir long-acting for pre-exposure prophylaxis during acute SHIV infection
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Physiologically‐Based Kinetic Modeling of Intravenously Administered Gold (Au) Nanoparticles
Cost-effectiveness of Cabotegravir Long-Acting for HIV Pre-exposure Prophylaxis in the United States
Population physiologically-based pharmacokinetic model incorporating lymphatic uptake for a subcutaneously administered pegylated peptide
Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
Novel Bilayer Microarray Patch‐Assisted Long‐Acting Micro‐Depot Cabotegravir Intradermal Delivery for HIV Pre‐Exposure Prophylaxis
Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions
Microneedle Optimization: Toward Enhancing Microneedle's Functionality and Breaking the Traditions